MyFinsight
Home
Blog
About
Contact
Download
Download image
Purchase under employee
stock purchase plan
$29,571
Net cash, and cash
equivalents provided by...
$29,571
Net increase in cash
and cash...
-$62,533,243
Canceled cashflow
$29,571
Stock-based compensation
expense
$7,767,694
Other current
liabilities
$2,308,706
Accounts payable
$1,395,428
Other current assets
-$1,357,508
Depreciation and
amortization
$723,352
Accrued payroll
liabilities
$155,219
Proceeds from asset
sales, net of legal...
$360,750
Net cash, cash
equivalents used in...
-$43,062,529
Net cash, and cash
equivalents used in...
-$19,500,285
Canceled cashflow
$13,707,907
Canceled cashflow
$360,750
Net loss
-$55,924,814
Purchase of short-term
investment
$19,854,723
Gain from asset sale
$360,750
Prepaid expenses
$302,928
Operating lease liability
-$181,944
Purchases of property and
equipment
$6,312
Back
Back
Cash Flow
source: myfinsight.com
Skye Bioscience, Inc. (SKYE)
Skye Bioscience, Inc. (SKYE)